Oruka Therapeutics, Inc. ORKA Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s cash ratio?
- Oruka Therapeutics, Inc. (ORKA) reported cash ratio of 3× in Q1 2026.
- How has Oruka Therapeutics, Inc.'s cash ratio changed year-over-year?
- Oruka Therapeutics, Inc.'s cash ratio decreased by 58.2% year-over-year, from 7.1× to 3×.
- What is the long-term trend for Oruka Therapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s cash ratio has grown at a -26.3% compound annual growth rate (CAGR), from 14× to 3.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.